Early Detection Diagnostics
Early detection and diagnostics play a crucial role in improving cancer outcomes by identifying the disease at its earliest, most treatable stages. Advances in imaging, blood tests, and biomarker analysis enhance accuracy, leading to timely interventions and better survival rates.
Study Expands Knowledge of Prognostic Markers in Extranodal NHL
Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper research considerations.
A new blood test accurately screens for colorectal cancer, researchers say
It could become the second to reach the market, and potentially help boost screening rates.
AI detects breast cancer years before diagnosis from mammograms
AI breakthroughs detect breast cancer 5 years early, revolutionizing diagnostics and offering hope for millions worldwide.
Peptide-Coated Nanoparticles Enhance Drug Delivery for Cancer Treatment
A new study reveals that peptide-coated nanoparticles can improve the delivery and efficacy of cancer drugs, potentially reducing side effects.
DNA-Tagged Gold Nanoparticles Enable Advanced Cancer Detection
Researchers have developed DNA-tagged gold nanoparticles that enhance the detection of cancer cells, offering a new avenue for early diagnosis.
Epigenetic states during development establish cancer risk before birth
A person’s lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study by Van Andel Institute scientists.
New study uncovers the biggest risk factor for colon cancer in under 35s — and it will shock you
Colon cancer cases among under 35s have almost doubled in the past three decades — leaving experts alarmed.
First study on ‘very young’ colon cancer patients reveals risk factors
A first-of-its-kind global study from researchers at Renmin Hospital of Wuhan University in China has revealed the main risk factors for early-onset colon cancer around the world.
Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
FRIDAY, Jan. 24, 2025 (HealthDay News) — Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct tr
New breakthrough in cancer research offers hope for early detection
Scientists have developed a novel method for early cancer detection, potentially increasing survival rates through earlier interventions.
Pfizer announces successful trial results for colorectal cancer drug
Pfizer’s latest clinical trial shows promising results for its new colorectal cancer drug, marking a significant advancement in treatment options.
Prostate cancer and AI: The exciting advances that could transform treatment
Exploring how artificial intelligence is revolutionizing prostate cancer treatment, from early detection to personalized therapy plans.
Video games could accelerate discoveries in cancer research
Cancer research is complex, but video games can help. Jeff Yoshimi believes gamers can contribute to scientific breakthroughs.
Biomarker algorithm for Barrett’s esophagus and esophageal cancer developed
By studying biomarkers known to be involved in gastrointestinal cancers, researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a biomarker algorithm that, when combined with a noninvasive method to collect esophageal cells for study, could give clinicians insight into which patients [SJMM1] have esophageal cancer or precancerous conditions such as Barrett’s esophagus (BE) or high-grade dysplasia. Typically, such determinations are made by endoscopy, an invasive procedure performed with patients under anesthesia.
Amgen Lumakras cleared for colorectal cancer (AMGN:NASDAQ) | Seeking Alpha
Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more here.
Triangulate Labs uses AI for skin cancer detection device – South Florida Business Journal
Last year, it entered into a licensing agreement with the Mayo Clinic to test its technology.
BeiGene wins US nod for Tevimbra label expansion (BGNE:NASDAQ) | Seeking Alpha
BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain gastric carcinoma. Read more here.
Chimerix files FDA application for brain cancer treatment – Triangle Business Journal
The Durham company is seeking a fast track to regulatory approval for its brain cancer treatment.
Nanoparticle Therapy Offers New Hope for Prostate Cancer Patients | University of Virginia School of Engineering and Applied Science
Prostate cancer is the second leading cause of cancer death among American men.
Zai Lab stock rises on Tivdak trial data (ZLAB:NASDAQ) | Seeking Alpha
Zai Lab (ZLAB) stock rose after positive trial data for its cervical cancer drug Tivdak and its plans to seek marketing approval for the drug in China. Read more here.
Bayers posts Phase 3 win for hot flashes drug (BAYRY:) (BAYRY) | Seeking Alpha
Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage trial. Read more here.
AI increases chances to detect breast cancer, study finds
Researchers have indicated the use of AI in breast cancer screening increases the chances of detecting the disease. There have been claims that AI could Researchers have indicated the use of AI in breast cancer screening increases
We Spoke To A Colorectal Cancer Doctor Who Shared 5 Things We Should All Stop Doing Immediately
Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.
